Voigtlander Christian B. 4

4 · ICU MEDICAL INC/DE · Filed May 21, 2025

Form 4

Period: 2025-05-20

Chief Operating Officer

Transactions

Exercise/Conversion
Common Stock
2025-05-20$96.83/sh+5,555$537,891→ 7,944 total
Sale
Common Stock
2025-05-21$133.00/sh−4,917$653,961→ 3,711 total
Exercise/Conversion
Common Stock
2025-05-21$96.83/sh+5,555$537,891→ 8,628 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-05-20−5,555→ 27,780 total
Exercise: $96.83From: 2016-06-04Exp: 2025-06-04→ Common Stock (5,555 underlying)
Sale
Common Stock
2025-05-20$137.11/sh−4,871$667,879→ 3,073 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-05-21−5,555→ 22,225 total
Exercise: $96.83From: 2016-06-04Exp: 2025-06-04→ Common Stock (5,555 underlying)

Footnotes (2)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.92 to $137.27, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F2]All shares sold were sold at the exact price disclosed.

Documents

1 file